Skip to main content

Advertisement

Table 4 Predictors of Hepatitis C treatment among patients referred to the hepatology (n = 163) and HIV primary care models (n = 196) in unadjusted and adjusted analyses

From: Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model

Covariate Unadjusted P value Adjusted P value
  OR (95% CI)   OR (95% CI)  
Hepatitis C treatment     
(HIV primary care vs. hepatology model ) 1.7 (1.0–2.9) 0.04 1.6 (0.9–2.8) 0.08
CD4+ cell count 1     
(≥400 vs. < 400 cells/mm3) 1.8 (1.1–3.03) 0.03 2.1 (1.2–3.6) 0.01
Having detectable HIV load     
(≥400 vs. < 400 copies/mL) 0.5 (0.3–1.1) 0.09 0.6 (0.3–1.1) 0.09
On any psychiatry medications     
(any vs. none) 0.6 (0.3–0.99) 0.04 0.5 (0.3–0.9) 0.02
Alanine aminotransferase levels     
(≥63 vs. < 63U/L) 1.9 (1.2–2.9) 0.002 1.4 (0.8–2.3) 0.3
Any neuropsychiatry history     
(yes vs. no) 0.7 (0.4–1.2) 0.17   
Age - years     
Per year increase 1.0 (0.9–1.03) 0.88   
Sex - biological     
(male vs. female) 1.2 (0.6–2.3) 0.65   
Race     
(white vs. non-white) 1.2 (0.6–2.5) 0.61   
Ethnicity:     
(non-hispanic vs. hispanic) 1.6 (0.2–13.4) 0.68   
HIV risk factors     
Men having sex with men Reference    
Heterosexual 1.6 (0.9–3.2) 0.14   
Intravenous drug use 0.4 (0.1–3.6) 0.44   
Hemophilia 1.3 (0.3–5.1) 0.68   
Combination 1.1 (0.5–2.1) 0.86   
Hepatitis C genotype 2     
(1/4 vs. 2/3) 0.8 (0.4–1.5) 0.50   
Liver biopsy scores 3     
(Proportion F3-4 vs. F0-2) 1.2 (0.6–2.5) 0.55   
Drugs or alcohol use within 3 months of     
HCV evaluation4     
(yes vs. no) 0.7 (0.4–1.3) 0.24   
HCV load - log10 copies/mL5     
(>6.33 vs. ≤ 6.33) 0.8 (0.5–1.4) 0.46   
Hemoglobin levels     
(>14.1 vs. ≤ 1 4.1 g/dL) 1.5 (0.8–2.6) 0.13   
Platelet count     
(>139 vs. ≤ 139 - 1000/mm3) 1.3 (0.8–2.1) 0.31   
INR levels     
(>1.1 vs. ≤1.1) 0.5 (0.2–1.3) 0.16   
  1. 1CD4+ counts available in 150 of 163 patients in the hepatology model and in all patients in HIV primary care model.
  2. 2 HCV genotype was not available in seven patients in hepatology model and one in HIV primary care model.
  3. 3 Liver biopsies: 70 in hepatology and 67 in HIV primary care models.
  4. 4 No data available in 47 patients in the hepatology model and in 9 patients in the HIV primary care model.
  5. 5 Two patients in the hepatology model had no available HCV viral load.